Dr. Joshua Richter Discusses Role of CELMoDs in Myeloma Treatment
Dr. Joshua Richter, director of Multiple Myeloma at the Blavatnik Family Chelsea Medical Center at Mount Sinai, recently outlined the potential applications of cerebron E3 ligase modulatory drugs (CELMoDs) such…